+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Renal Dialysis Equipment Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

  • PDF Icon


  • 115 Pages
  • June 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4896063
UP TO OFF until Dec 31st 2023
The global renal dialysis equipment market is expected to register a CAGR of 9.8% over the forecast period.

According to Johns Hopkins University, some people infected with COVID-19 showed signs of kidney damage, and even those who had no prior kidney problems were infected. Furthermore, approximately 30% of COVID-19 patients hospitalized in New York and China developed moderate or severe kidney injury. Atypical blood work and high levels of protein in the urine are signs of kidney problems in COVID-19 patients, which can lead to kidney damage and the need for dialysis in some cases. According to the National Kidney Foundation Inc., people on dialysis may be at a higher risk of severe disease from COVID-19 in 2020. For severe cases, patient recovery may take six weeks or more. About 1% of infected patients will die from the disease. Thus, COVID-19 has a profound impact on the market studied.

Some of the factors driving the market growth include primarily attributed to the rise in the number of end-stage renal disease patients (ESRD), growing demand for peritoneal dialysis, rise in cost-effective and accurate portable dialysis apparatus, and advanced technologies.

The renal dialysis equipment market is expected to show good growth due to the expanding number of dialysis centers, growth in R&D expenditure for the development of new dialysis products, and increasing end-stage renal diseases. In January 2019, Baxter International Inc. received the US FDA approval for its clinical trial on-demand peritoneal dialysis solution generation system. The new system offers a good platform for patients to perform dialysis at home.

Globally, there has been an increase in the incidence of renal diseases, such as kidney diseases, in developed and developing countries. Dialysis is referred to patients with end-stage renal disorder (ESRD) or chronic kidney diseases. According to the National Institute of Medicine July 2020, urinary tract infection affects approximately 150 million people globally. In addition, approximately 11% women visit one physician in a year for urinary tract infection treatment. Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Additionally, according to the article published in the International Journal of Molecular medicine in August 2020, Kidney stone disease, also known as nephrolithiasis or urolithiasis, is one of medicine's oldest diseases. It is estimated that 11% of people will develop kidney stones at some point in their lives, and the prevalence and incidence of kidney stones are increasing worldwide. However, overall prevalence of urolithiasis was 11.2 %, with 48.8 % having a first-degree relative with the disease. Males were 1.8 times more likely than females to have urolithiasis.

According to a research study by Jennifer A Hirst et al., published in the British Journal of General Practice August2020, about 44.0% of people in the United Kingdom with chronic kidney disease (CKD) were undiagnosed without screening, and the prevalence of chronic kidney disease (CKD) stages 1-5 was 18.2% in patients aged above 60 years. Thus, the increasing burden of disease is expected to boost the market growth over the forecast period. However, factors, such as complications and risks associated with dialysis and reimbursement issues, may impede the market growth over the forecast period.

Key Market Trends

Hemodialysis (HD) Equipment is Expected to Hold Significant Market Share During the Forecast Period

Globally, hemodialysis equipment adoption is steadily increasing due to the increasing prevalence of kidney failure patients. It is used to filter wastes and water from the blood. Thus, market players are found focusing on the developments of the new hemodialysis equipment that help in the growth of the overall market.

COVID‐19 is a very high transmission infectious disease with a variable prognosis in the general population. Patients in hemodialysis therapy are vulnerable to developing an infectious disease. Moreover, COVID‐19 is a very high transmission disease, and risk factors such as age, hypertension, diabetes, cancer, and chronic respiratory and cardiovascular disease are associated with the worst prognosis. For instance, according to a research article by Claudia Benedetti et al., published in Frontiers in Medicine Journal 2020, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients for a more severe disease course. COVID-19 infects the kidneys and may induce acute kidney injury.

Furthermore, a research article by Meritxell Ibernon et al., published in Hemodialysis International Journal 2020, found that COVID-19 has shown a high incidence and mortality rate in hemodialysis patients. Thus, early preventive measures against COVID-19 could decrease the risk of spreading disease in vulnerable patients.

Some of the factors which are driving the segment growth include the rising prevalence of kidney diseases such as end-stage renal disease (ESRD), along with increasing innovative product launches in the market by market players.

According to the National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, ESKD, also known as end-stage renal disease (ESRD), affects almost 786,000 people in the United States, with 71% requiring dialysis and 29% requiring a kidney transplant. ESKD affects three men for every two women who develop it. However, most of the population remains undiagnosed in the early stages, eventually leading to death, worldwide.

Furthermore, technological advancements in healthcare are leading to the development of hemodialysis machines with improved ergonomics. For instance, in 2019, Fresenius Medical Care launched 4008A, an advanced hemodialysis machine in the Indian market. The newly launched machine is equipped with new blood filtration technology. Thus, the above-mentioned mentioned factors are expected to drive segment growth over the forecast period.

North America is Expected to Dominate the Renal Dialysis Equipment Market Over the Forecast Period

The factors driving the market growth in North American include the massive adoption of new technologies in the kidney dialysis division. There is also a boom in public healthcare expenditure and an increase in awareness programs about the availability of advanced treatments.

The novel coronavirus disease 2019 (COVID-19) has a high mortality rate among older adults and individuals suffering from chronic diseases, such as chronic kidney diseases (CKD). As per the Centers for Disease Control and Prevention (CDC) 2019, in the United States, about 15% of adults suffer from chronic kidney diseases (CKD).

Furthermore, in the United States, patients with pre-existing chronic kidney disease (CKD) were considered to be largely susceptible to COVID-19. For instance, a research article by Jennifer E Flythe et al., published in the American Journal of Kidney Diseases 2020, stated that high mortality can be observed in patients with underlying kidney disease and severe COVID-19.

According to a research article by Pietro Ravani et al., published in JAMA Journal 2020, the study results found that the incidence rate of stage IV chronic kidney disease increased with advancing age. For those aged 75 years and older, the risk of death was much higher than the risk of kidney failure. The high burden of chronic kidney disease is expected to boost the market, increasing the demand for renal dialysis in the coming years.

Some of the market players involved in the US market include DaVita, Baxter International, Medtronic, and U.S. Renal Care. These players adopted various strategies, such as collaborations, mergers, acquisitions, and product innovations, to maintain their market position. in December 2020, Medtronic PLC launched the first and only pediatric and neonatal acute dialysis machine in the United States. Similarly, in October 2020, the United States-based privately held medical device company, Diality, invested around USD 12.5 million in developing a portable hemodialysis system to address the unmet technology needs of the evolving dialysis industry.

Thus, the above-mentioned factors are expected to drive market growth over the forecast period.

Competitive Landscape

The renal dialysis equipment market is fragmented and competitive, with several market players. Some of the market players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions, to increase their footprints in this market. Some of the market players include Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International Inc., Nikkiso Co. Ltd, and Nipro Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand for Peritoneal Dialysis
4.2.2 Growth in R&D Expenditure for the Development of New Dialysis Products
4.2.3 Increasing Prevalence of Kidney Disease
4.3 Market Restraints
4.3.1 Complications and Risks Associated with Dialysis
4.3.2 Reimbursement Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Hemodialysis (HD) Equipment
5.1.2 Peritoneal Dialysis (PD) Equipment
5.1.3 Concentrates and Solutions
5.1.4 Catheters and Tubings
5.1.5 Other Products
5.2 By Application
5.2.1 Hemodialysis
5.2.2 Peritoneal Dialysis
5.3 By End User
5.3.1 In-Center Dialysis Settings
5.3.2 Home Care Settings
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Fresenius Kabi AG
6.1.2 Baxter International, Inc.
6.1.3 Nipro Corporation
6.1.4 B. Braun Melsungen AG
6.1.5 Nikkiso Co. Ltd
6.1.6 Asahi Kasei Corporation
6.1.7 Medtronic PLC
6.1.8 Rockwell Medical
6.1.9 Teleflex Incorporated
6.1.10 Medivators Inc
6.1.11 Toray Medical Co. Ltd
6.1.12 Hemoclean Co. Ltd
6.1.13 Medtronic PLC
6.1.14 Quanta
6.1.15 Outset Medical Inc.


Companies Mentioned

A selection of companies mentioned in this report includes:

  • Fresenius Kabi AG
  • Baxter International, Inc.
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd
  • Asahi Kasei Corporation
  • Medtronic PLC
  • Rockwell Medical
  • Teleflex Incorporated
  • Medivators Inc
  • Toray Medical Co. Ltd
  • Hemoclean Co. Ltd
  • Medtronic PLC
  • Quanta
  • Outset Medical Inc.